NALTREXONE / BUPROPION M/R (Mysimba®)
Clinical Indication
Managing obesity
Comments
NICE TA 494 not supported for managing obesity in adults
Date of classification
February 2018
Do not prescribe
Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.